Viracta Therapeutics Pink Sheet Forecast - Simple Moving Average

VIRXDelisted Stock  USD 0.03  0  7.38%   
The Simple Moving Average forecasted value of Viracta Therapeutics on the next trading day is expected to be 0.03 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.83. Viracta Pink Sheet Forecast is based on your current time horizon.
  
A two period moving average forecast for Viracta Therapeutics is based on an daily price series in which the stock price on a given day is replaced by the mean of that price and the preceding price. This model is best suited to price patterns experiencing average volatility.

Viracta Therapeutics Simple Moving Average Price Forecast For the 23rd of March

Given 90 days horizon, the Simple Moving Average forecasted value of Viracta Therapeutics on the next trading day is expected to be 0.03 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.0005, and the sum of the absolute errors of 0.83.
Please note that although there have been many attempts to predict Viracta Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Viracta Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Viracta Therapeutics Pink Sheet Forecast Pattern

Backtest Viracta TherapeuticsViracta Therapeutics Price PredictionBuy or Sell Advice 

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Viracta Therapeutics pink sheet data series using in forecasting. Note that when a statistical model is used to represent Viracta Therapeutics pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria106.8933
BiasArithmetic mean of the errors 0.0038
MADMean absolute deviation0.0142
MAPEMean absolute percentage error0.1336
SAESum of the absolute errors0.8349
The simple moving average model is conceptually a linear regression of the current value of Viracta Therapeutics price series against current and previous (unobserved) value of Viracta Therapeutics. In time series analysis, the simple moving-average model is a very common approach for modeling univariate price series models including forecasting prices into the future

Predictive Modules for Viracta Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Viracta Therapeutics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.0316.01
Details
Intrinsic
Valuation
LowRealHigh
0.000.0316.01
Details

View Viracta Therapeutics Related Equities

 Risk & Return  Correlation

Viracta Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Viracta Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Viracta Therapeutics shares will generate the highest return on investment. By undertsting and applying Viracta Therapeutics pink sheet market strength indicators, traders can identify Viracta Therapeutics entry and exit signals to maximize returns.

Viracta Therapeutics Risk Indicators

The analysis of Viracta Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Viracta Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting viracta pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Consideration for investing in Viracta Pink Sheet

If you are still planning to invest in Viracta Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Viracta Therapeutics' history and understand the potential risks before investing.
Transaction History
View history of all your transactions and understand their impact on performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Global Correlations
Find global opportunities by holding instruments from different markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
CEOs Directory
Screen CEOs from public companies around the world